Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Gremmel

Showing results (51-60 of 133) with videos related to

Pageof 14
Sort By:
Thrombosis Research|May 31, 2011
The influencing factors for clopidogrel-mediated platelet inhibition are assay-dependentThomas Gremmel, Sabine Steiner, Daniela Seidinger, et al.
Angiology|February 11, 2016
The Antiplatelet Effect of Clopidogrel Decreases With Patient AgeEndri Xhelili, Beate Eichelberger, Christoph W Kopp, et al.
Thrombosis Research|July 28, 2009
Smoking promotes clopidogrel-mediated platelet inhibition in patients receiving dual antiplatelet therapyThomas Gremmel, Sabine Steiner, Daniela Seidinger, et al.
European Journal of Clinical Investigation|April 25, 2013
Preserved thrombin-inducible platelet activation in thienopyridine-treated patientsThomas Gremmel, Christoph W Kopp, Daniela Seidinger, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|April 16, 2014
Human neutrophil α-defensins are associated with adenosine diphosphate-inducible neutrophil-platelet aggregate formation and response to clopidogrel in patients with atherosclerosisThomas Gremmel, Markus Durstberger, Beate Eichelberger, et al.
Swiss Medical Weekly|June 7, 2013
Impact of diabetes on platelet activation in different manifestations of atherosclerosisThomas Gremmel, Christoph W Kopp, Daniela Seidinger, et al.
Thrombosis and Haemostasis|February 5, 2009
Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantationThomas Gremmel, Sabine Steiner, Daniela Seidinger, et al.
Heart (British Cardiac Society)|August 19, 2009
Calcium-channel blockers decrease clopidogrel-mediated platelet inhibitionThomas Gremmel, Sabine Steiner, Daniela Seidinger, et al.
Atherosclerosis|January 10, 2014
Response to antiplatelet therapy and platelet reactivity to thrombin receptor activating peptide-6 in cardiovascular interventions: Differences between peripheral and coronary angioplastyThomas Gremmel, Endri Xhelili, Sabine Steiner, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|June 23, 2016
Serum Cholinesterase Levels Are Associated With 2-Year Ischemic Outcomes After Angioplasty and Stenting for Peripheral Artery DiseaseThomas Gremmel, Patricia P Wadowski, Markus Mueller, et al.
Pageof 14

Showing results (51-60 of 133) with videos related to

Sort By:
Pageof 14
Thrombosis Research|May 31, 2011
The influencing factors for clopidogrel-mediated platelet inhibition are assay-dependentThomas Gremmel, Sabine Steiner, Daniela Seidinger, et al.
Angiology|February 11, 2016
The Antiplatelet Effect of Clopidogrel Decreases With Patient AgeEndri Xhelili, Beate Eichelberger, Christoph W Kopp, et al.
Thrombosis Research|July 28, 2009
Smoking promotes clopidogrel-mediated platelet inhibition in patients receiving dual antiplatelet therapyThomas Gremmel, Sabine Steiner, Daniela Seidinger, et al.
European Journal of Clinical Investigation|April 25, 2013
Preserved thrombin-inducible platelet activation in thienopyridine-treated patientsThomas Gremmel, Christoph W Kopp, Daniela Seidinger, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|April 16, 2014
Human neutrophil α-defensins are associated with adenosine diphosphate-inducible neutrophil-platelet aggregate formation and response to clopidogrel in patients with atherosclerosisThomas Gremmel, Markus Durstberger, Beate Eichelberger, et al.
Swiss Medical Weekly|June 7, 2013
Impact of diabetes on platelet activation in different manifestations of atherosclerosisThomas Gremmel, Christoph W Kopp, Daniela Seidinger, et al.
Thrombosis and Haemostasis|February 5, 2009
Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantationThomas Gremmel, Sabine Steiner, Daniela Seidinger, et al.
Heart (British Cardiac Society)|August 19, 2009
Calcium-channel blockers decrease clopidogrel-mediated platelet inhibitionThomas Gremmel, Sabine Steiner, Daniela Seidinger, et al.
Atherosclerosis|January 10, 2014
Response to antiplatelet therapy and platelet reactivity to thrombin receptor activating peptide-6 in cardiovascular interventions: Differences between peripheral and coronary angioplastyThomas Gremmel, Endri Xhelili, Sabine Steiner, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|June 23, 2016
Serum Cholinesterase Levels Are Associated With 2-Year Ischemic Outcomes After Angioplasty and Stenting for Peripheral Artery DiseaseThomas Gremmel, Patricia P Wadowski, Markus Mueller, et al.
Pageof 14